HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-NOV-18 6MYN TITLE CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO TITLE 2 INHIBITOR R7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NF-KAPPA-BETA-INDUCING KINASE,SERINE/THREONINE-PROTEIN COMPND 5 KINASE NIK; COMPND 6 EC: 2.7.11.25; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAP3K14, NIK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS NIK, KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.HARRIS,M.SMITH,J.BARKER REVDAT 4 13-MAR-24 6MYN 1 REMARK REVDAT 3 02-OCT-19 6MYN 1 JRNL REVDAT 2 14-AUG-19 6MYN 1 JRNL REVDAT 1 07-AUG-19 6MYN 0 JRNL AUTH J.A.FENG,P.LEE,M.H.ALAOUI,K.BARRETT,G.CASTANEDO,R.GODEMANN, JRNL AUTH 2 P.MCEWAN,X.WANG,P.WU,Y.ZHANG,S.F.HARRIS,S.T.STABEN JRNL TITL STRUCTURE BASED DESIGN OF POTENT SELECTIVE INHIBITORS OF JRNL TITL 2 PROTEIN KINASE D1 (PKD1). JRNL REF ACS MED.CHEM.LETT. V. 10 1260 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31531194 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00658 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.W.FENG,P.LEE,M.H.ALAOUI,K.BARRETT,G.M.CASTANEDA, REMARK 1 AUTH 2 R.GODEMANN,P.MCEWAN,X.WANG,P.WU,Y.ZHANG,S.F.HARRIS, REMARK 1 AUTH 3 S.T.STABEN REMARK 1 TITL STRUCTURE BASED DESIGN OF POTENT SELECTIVE INHIBITORS OF REMARK 1 TITL 2 PROTEIN KINASE D1 (PKD1) REMARK 1 REF ACS MED.CHEM.LETT. 2019 REMARK 1 REFN ISSN 1948-5875 REMARK 1 DOI 10.1021/ACSMEDCHEMLETT.8B0065 REMARK 2 REMARK 2 RESOLUTION. 2.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12-2829_FINAL REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 25125 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.360 REMARK 3 FREE R VALUE TEST SET COUNT : 2603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.1957 - 7.3111 1.00 1284 134 0.1653 0.1967 REMARK 3 2 7.3111 - 5.8079 1.00 1201 143 0.1625 0.2088 REMARK 3 3 5.8079 - 5.0751 1.00 1225 119 0.1627 0.2431 REMARK 3 4 5.0751 - 4.6117 1.00 1196 125 0.1420 0.2359 REMARK 3 5 4.6117 - 4.2815 1.00 1218 125 0.1322 0.2037 REMARK 3 6 4.2815 - 4.0293 1.00 1173 169 0.1469 0.2172 REMARK 3 7 4.0293 - 3.8276 1.00 1170 130 0.1605 0.2382 REMARK 3 8 3.8276 - 3.6611 1.00 1187 130 0.1716 0.2631 REMARK 3 9 3.6611 - 3.5202 1.00 1167 148 0.1756 0.2619 REMARK 3 10 3.5202 - 3.3988 1.00 1183 137 0.2049 0.2953 REMARK 3 11 3.3988 - 3.2926 1.00 1165 145 0.2075 0.2729 REMARK 3 12 3.2926 - 3.1985 1.00 1195 119 0.2094 0.3036 REMARK 3 13 3.1985 - 3.1143 1.00 1158 131 0.2186 0.2775 REMARK 3 14 3.1143 - 3.0384 1.00 1207 130 0.2277 0.3394 REMARK 3 15 3.0384 - 2.9693 1.00 1181 120 0.2309 0.3651 REMARK 3 16 2.9693 - 2.9061 1.00 1120 164 0.2731 0.3663 REMARK 3 17 2.9061 - 2.8480 1.00 1177 141 0.2848 0.3643 REMARK 3 18 2.8480 - 2.7943 1.00 1170 140 0.2776 0.3853 REMARK 3 19 2.7943 - 2.7444 1.00 1145 153 0.2902 0.3551 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.470 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 5301 REMARK 3 ANGLE : 1.128 7190 REMARK 3 CHIRALITY : 0.057 764 REMARK 3 PLANARITY : 0.007 976 REMARK 3 DIHEDRAL : 16.567 3214 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MYN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000237851. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25142 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.744 REMARK 200 RESOLUTION RANGE LOW (A) : 44.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08600 REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : 0.69000 REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE TRIBASIC REMARK 280 DIHYDRATE (PH 6.2), 0.5 M AMMONIUM SULFATE, 0.9 M LITHIUM REMARK 280 SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.20500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.80750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 11.60250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 329 REMARK 465 LEU A 330 REMARK 465 GLU A 331 REMARK 465 LYS A 332 REMARK 465 VAL A 333 REMARK 465 SER A 364 REMARK 465 GLY A 365 REMARK 465 SER A 366 REMARK 465 ALA A 367 REMARK 465 LYS A 368 REMARK 465 LEU A 369 REMARK 465 GLN A 370 REMARK 465 ARG A 371 REMARK 465 LEU A 372 REMARK 465 GLY A 373 REMARK 465 PRO A 374 REMARK 465 GLU A 375 REMARK 465 THR A 376 REMARK 465 GLU A 377 REMARK 465 PRO A 545 REMARK 465 ASP A 546 REMARK 465 GLY A 547 REMARK 465 LEU A 548 REMARK 465 GLY A 549 REMARK 465 LYS A 550 REMARK 465 ALA B 329 REMARK 465 LEU B 330 REMARK 465 GLU B 331 REMARK 465 LYS B 332 REMARK 465 VAL B 333 REMARK 465 SER B 364 REMARK 465 GLY B 365 REMARK 465 SER B 366 REMARK 465 ALA B 367 REMARK 465 LYS B 368 REMARK 465 LEU B 369 REMARK 465 GLN B 370 REMARK 465 ARG B 371 REMARK 465 LEU B 372 REMARK 465 GLY B 373 REMARK 465 PRO B 374 REMARK 465 GLU B 375 REMARK 465 THR B 376 REMARK 465 GLU B 377 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 551 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 392 NH1 ARG B 407 1.86 REMARK 500 OD2 ASP A 536 F17 K6Y A 703 1.94 REMARK 500 NZ LYS A 664 O HOH A 801 2.05 REMARK 500 NE2 GLN A 658 O HOH A 802 2.15 REMARK 500 O HOH A 831 O HOH A 858 2.15 REMARK 500 O LEU B 489 O HOH B 801 2.17 REMARK 500 OE1 GLU A 634 NZ LYS A 652 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 362 21.90 -76.66 REMARK 500 GLU A 398 -4.18 79.60 REMARK 500 GLN A 405 -155.95 53.55 REMARK 500 ARG A 410 -1.82 -150.71 REMARK 500 CYS A 428 -162.97 -166.75 REMARK 500 ASP A 517 58.07 -154.60 REMARK 500 SER A 526 -179.38 -61.04 REMARK 500 ASP A 536 97.99 64.35 REMARK 500 LEU A 553 58.58 -91.85 REMARK 500 ASP A 556 27.21 -72.16 REMARK 500 ASP A 576 -169.22 -129.33 REMARK 500 TRP A 598 -31.91 76.01 REMARK 500 PRO A 605 106.66 -54.20 REMARK 500 PRO A 616 40.22 -70.54 REMARK 500 LYS A 668 72.34 -112.95 REMARK 500 PRO A 674 -168.21 -71.13 REMARK 500 ASP B 392 66.09 38.18 REMARK 500 VAL B 399 -61.22 -104.58 REMARK 500 GLN B 405 -82.93 -38.18 REMARK 500 SER B 412 -31.74 -35.43 REMARK 500 SER B 450 110.77 -162.31 REMARK 500 ASP B 517 52.14 -149.14 REMARK 500 ASP B 536 94.89 70.58 REMARK 500 LYS B 573 168.70 -46.78 REMARK 500 ALA B 577 -1.90 -59.05 REMARK 500 TRP B 598 -17.64 71.68 REMARK 500 PRO B 605 102.89 -55.93 REMARK 500 PRO B 616 45.33 -73.44 REMARK 500 ALA B 625 159.38 -47.89 REMARK 500 SER B 665 152.67 -42.57 REMARK 500 LYS B 668 -41.55 76.93 REMARK 500 PRO B 674 -168.15 -58.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K6Y A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K6Y B 704 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4G3C RELATED DB: PDB REMARK 900 4G3C CONTAINS APO STRUCTURE OF THE SAME PROTEIN DBREF 6MYN A 329 675 UNP Q9WUL6 M3K14_MOUSE 329 675 DBREF 6MYN B 329 675 UNP Q9WUL6 M3K14_MOUSE 329 675 SEQRES 1 A 347 ALA LEU GLU LYS VAL PRO VAL GLU GLU TYR LEU VAL HIS SEQRES 2 A 347 ALA LEU GLN GLY SER VAL SER SER GLY GLN ALA HIS SER SEQRES 3 A 347 LEU ALA SER LEU ALA LYS THR TRP SER SER GLY SER ALA SEQRES 4 A 347 LYS LEU GLN ARG LEU GLY PRO GLU THR GLU ASP ASN GLU SEQRES 5 A 347 GLY VAL LEU LEU THR GLU LYS LEU LYS PRO VAL ASP TYR SEQRES 6 A 347 GLU TYR ARG GLU GLU VAL HIS TRP MET THR HIS GLN PRO SEQRES 7 A 347 ARG VAL GLY ARG GLY SER PHE GLY GLU VAL HIS ARG MET SEQRES 8 A 347 LYS ASP LYS GLN THR GLY PHE GLN CYS ALA VAL LYS LYS SEQRES 9 A 347 VAL ARG LEU GLU VAL PHE ARG VAL GLU GLU LEU VAL ALA SEQRES 10 A 347 CYS ALA GLY LEU SER SER PRO ARG ILE VAL PRO LEU TYR SEQRES 11 A 347 GLY ALA VAL ARG GLU GLY PRO TRP VAL ASN ILE PHE MET SEQRES 12 A 347 GLU LEU LEU GLU GLY GLY SER LEU GLY GLN LEU ILE LYS SEQRES 13 A 347 GLN MET GLY CYS LEU PRO GLU ASP ARG ALA LEU TYR TYR SEQRES 14 A 347 LEU GLY GLN ALA LEU GLU GLY LEU GLU TYR LEU HIS THR SEQRES 15 A 347 ARG ARG ILE LEU HIS GLY ASP VAL LYS ALA ASP ASN VAL SEQRES 16 A 347 LEU LEU SER SER ASP GLY SER ARG ALA ALA LEU CYS ASP SEQRES 17 A 347 PHE GLY HIS ALA LEU CYS LEU GLN PRO ASP GLY LEU GLY SEQRES 18 A 347 LYS SER LEU LEU THR GLY ASP TYR ILE PRO GLY THR GLU SEQRES 19 A 347 THR HIS MET ALA PRO GLU VAL VAL MET GLY LYS PRO CYS SEQRES 20 A 347 ASP ALA LYS VAL ASP ILE TRP SER SER CYS CYS MET MET SEQRES 21 A 347 LEU HIS MET LEU ASN GLY CYS HIS PRO TRP THR GLN TYR SEQRES 22 A 347 PHE ARG GLY PRO LEU CYS LEU LYS ILE ALA SER GLU PRO SEQRES 23 A 347 PRO PRO ILE ARG GLU ILE PRO PRO SER CYS ALA PRO LEU SEQRES 24 A 347 THR ALA GLN ALA ILE GLN GLU GLY LEU ARG LYS GLU PRO SEQRES 25 A 347 VAL HIS ARG ALA SER ALA MET GLU LEU ARG ARG LYS VAL SEQRES 26 A 347 GLY LYS ALA LEU GLN GLU VAL GLY GLY LEU LYS SER PRO SEQRES 27 A 347 TRP LYS GLY GLU TYR LYS GLU PRO ARG SEQRES 1 B 347 ALA LEU GLU LYS VAL PRO VAL GLU GLU TYR LEU VAL HIS SEQRES 2 B 347 ALA LEU GLN GLY SER VAL SER SER GLY GLN ALA HIS SER SEQRES 3 B 347 LEU ALA SER LEU ALA LYS THR TRP SER SER GLY SER ALA SEQRES 4 B 347 LYS LEU GLN ARG LEU GLY PRO GLU THR GLU ASP ASN GLU SEQRES 5 B 347 GLY VAL LEU LEU THR GLU LYS LEU LYS PRO VAL ASP TYR SEQRES 6 B 347 GLU TYR ARG GLU GLU VAL HIS TRP MET THR HIS GLN PRO SEQRES 7 B 347 ARG VAL GLY ARG GLY SER PHE GLY GLU VAL HIS ARG MET SEQRES 8 B 347 LYS ASP LYS GLN THR GLY PHE GLN CYS ALA VAL LYS LYS SEQRES 9 B 347 VAL ARG LEU GLU VAL PHE ARG VAL GLU GLU LEU VAL ALA SEQRES 10 B 347 CYS ALA GLY LEU SER SER PRO ARG ILE VAL PRO LEU TYR SEQRES 11 B 347 GLY ALA VAL ARG GLU GLY PRO TRP VAL ASN ILE PHE MET SEQRES 12 B 347 GLU LEU LEU GLU GLY GLY SER LEU GLY GLN LEU ILE LYS SEQRES 13 B 347 GLN MET GLY CYS LEU PRO GLU ASP ARG ALA LEU TYR TYR SEQRES 14 B 347 LEU GLY GLN ALA LEU GLU GLY LEU GLU TYR LEU HIS THR SEQRES 15 B 347 ARG ARG ILE LEU HIS GLY ASP VAL LYS ALA ASP ASN VAL SEQRES 16 B 347 LEU LEU SER SER ASP GLY SER ARG ALA ALA LEU CYS ASP SEQRES 17 B 347 PHE GLY HIS ALA LEU CYS LEU GLN PRO ASP GLY LEU GLY SEQRES 18 B 347 LYS SER LEU LEU THR GLY ASP TYR ILE PRO GLY THR GLU SEQRES 19 B 347 THR HIS MET ALA PRO GLU VAL VAL MET GLY LYS PRO CYS SEQRES 20 B 347 ASP ALA LYS VAL ASP ILE TRP SER SER CYS CYS MET MET SEQRES 21 B 347 LEU HIS MET LEU ASN GLY CYS HIS PRO TRP THR GLN TYR SEQRES 22 B 347 PHE ARG GLY PRO LEU CYS LEU LYS ILE ALA SER GLU PRO SEQRES 23 B 347 PRO PRO ILE ARG GLU ILE PRO PRO SER CYS ALA PRO LEU SEQRES 24 B 347 THR ALA GLN ALA ILE GLN GLU GLY LEU ARG LYS GLU PRO SEQRES 25 B 347 VAL HIS ARG ALA SER ALA MET GLU LEU ARG ARG LYS VAL SEQRES 26 B 347 GLY LYS ALA LEU GLN GLU VAL GLY GLY LEU LYS SER PRO SEQRES 27 B 347 TRP LYS GLY GLU TYR LYS GLU PRO ARG HET SO4 A 701 5 HET SO4 A 702 5 HET K6Y A 703 34 HET SO4 B 701 5 HET SO4 B 702 5 HET SO4 B 703 5 HET K6Y B 704 34 HETNAM SO4 SULFATE ION HETNAM K6Y (5S,7S)-9-FLUORO-10-[(3R)-3-HYDROXY-3-(5-METHYL-1,2- HETNAM 2 K6Y OXAZOL-3-YL)BUT-1-YN-1-YL]-N~3~-METHYL-6,7-DIHYDRO-5H- HETNAM 3 K6Y 5,7-METHANOIMIDAZO[2,1-A][2]BENZAZEPINE-2,3- HETNAM 4 K6Y DICARBOXAMIDE FORMUL 3 SO4 5(O4 S 2-) FORMUL 5 K6Y 2(C24 H22 F N5 O4) FORMUL 10 HOH *105(H2 O) HELIX 1 AA1 VAL A 335 GLN A 344 1 10 HELIX 2 AA2 GLN A 351 LYS A 360 1 10 HELIX 3 AA3 THR A 361 SER A 363 5 3 HELIX 4 AA4 GLU A 436 ARG A 439 5 4 HELIX 5 AA5 VAL A 440 ALA A 445 1 6 HELIX 6 AA6 SER A 478 GLY A 487 1 10 HELIX 7 AA7 PRO A 490 ARG A 511 1 22 HELIX 8 AA8 LYS A 519 ASP A 521 5 3 HELIX 9 AA9 THR A 561 MET A 565 5 5 HELIX 10 AB1 ALA A 566 GLY A 572 1 7 HELIX 11 AB2 ALA A 577 GLY A 594 1 18 HELIX 12 AB3 PRO A 605 GLU A 613 1 9 HELIX 13 AB4 PRO A 615 ILE A 620 5 6 HELIX 14 AB5 ALA A 625 GLY A 635 1 11 HELIX 15 AB6 SER A 645 VAL A 660 1 16 HELIX 16 AB7 VAL B 335 GLN B 344 1 10 HELIX 17 AB8 GLN B 351 THR B 361 1 11 HELIX 18 AB9 GLU B 436 ARG B 439 5 4 HELIX 19 AC1 VAL B 440 ALA B 445 1 6 HELIX 20 AC2 SER B 478 GLY B 487 1 10 HELIX 21 AC3 PRO B 490 ARG B 511 1 22 HELIX 22 AC4 LYS B 519 ASP B 521 5 3 HELIX 23 AC5 THR B 561 MET B 565 5 5 HELIX 24 AC6 ALA B 566 MET B 571 1 6 HELIX 25 AC7 ALA B 577 GLY B 594 1 18 HELIX 26 AC8 PRO B 605 GLU B 613 1 9 HELIX 27 AC9 PRO B 615 ILE B 620 5 6 HELIX 28 AD1 ALA B 625 LEU B 636 1 12 HELIX 29 AD2 SER B 645 VAL B 660 1 16 SHEET 1 AA1 7 VAL A 347 SER A 349 0 SHEET 2 AA1 7 ASN A 379 LEU A 383 1 O LEU A 383 N SER A 348 SHEET 3 AA1 7 LEU A 457 GLU A 463 -1 O ARG A 462 N GLU A 380 SHEET 4 AA1 7 TRP A 466 MET A 471 -1 O ASN A 468 N VAL A 461 SHEET 5 AA1 7 GLN A 427 ARG A 434 -1 N VAL A 433 O VAL A 467 SHEET 6 AA1 7 VAL A 416 ASP A 421 -1 N HIS A 417 O VAL A 430 SHEET 7 AA1 7 TRP A 401 THR A 403 -1 N MET A 402 O LYS A 420 SHEET 1 AA2 2 ILE A 513 LEU A 514 0 SHEET 2 AA2 2 LEU A 541 CYS A 542 -1 O LEU A 541 N LEU A 514 SHEET 1 AA3 2 VAL A 523 LEU A 525 0 SHEET 2 AA3 2 ALA A 532 LEU A 534 -1 O ALA A 533 N LEU A 524 SHEET 1 AA4 7 VAL B 347 SER B 349 0 SHEET 2 AA4 7 ASN B 379 LEU B 383 1 O LEU B 383 N SER B 348 SHEET 3 AA4 7 LEU B 457 GLU B 463 -1 O ARG B 462 N GLU B 380 SHEET 4 AA4 7 TRP B 466 MET B 471 -1 O TRP B 466 N GLU B 463 SHEET 5 AA4 7 GLN B 427 ARG B 434 -1 N LYS B 431 O ILE B 469 SHEET 6 AA4 7 VAL B 416 ASP B 421 -1 N HIS B 417 O VAL B 430 SHEET 7 AA4 7 TRP B 401 THR B 403 -1 N MET B 402 O LYS B 420 SHEET 1 AA5 2 ILE B 513 LEU B 514 0 SHEET 2 AA5 2 LEU B 541 CYS B 542 -1 O LEU B 541 N LEU B 514 SHEET 1 AA6 2 VAL B 523 LEU B 525 0 SHEET 2 AA6 2 ALA B 532 LEU B 534 -1 O ALA B 533 N LEU B 524 SHEET 1 AA7 2 LYS B 550 SER B 551 0 SHEET 2 AA7 2 PRO B 574 CYS B 575 -1 O CYS B 575 N LYS B 550 SITE 1 AC1 4 ARG A 637 LYS A 638 GLU A 639 HOH A 810 SITE 1 AC2 2 ARG A 650 ARG A 651 SITE 1 AC3 18 ARG A 410 GLY A 411 VAL A 416 ALA A 429 SITE 2 AC3 18 LYS A 431 GLU A 442 VAL A 455 ILE A 469 SITE 3 AC3 18 MET A 471 GLU A 472 LEU A 473 LEU A 474 SITE 4 AC3 18 GLY A 477 ASP A 521 LEU A 524 CYS A 535 SITE 5 AC3 18 ASP A 536 PHE A 537 SITE 1 AC4 5 ARG B 637 LYS B 638 GLU B 639 HIS B 642 SITE 2 AC4 5 HOH B 813 SITE 1 AC5 2 ARG B 453 HOH B 806 SITE 1 AC6 7 LYS A 519 THR A 561 HIS A 596 GLN B 351 SITE 2 AC6 7 HOH B 810 HOH B 815 HOH B 818 SITE 1 AC7 17 ARG B 410 GLY B 411 ALA B 429 LYS B 431 SITE 2 AC7 17 GLU B 442 VAL B 455 ILE B 469 MET B 471 SITE 3 AC7 17 GLU B 472 LEU B 473 LEU B 474 GLY B 477 SITE 4 AC7 17 ASP B 521 LEU B 524 CYS B 535 ASP B 536 SITE 5 AC7 17 PHE B 537 CRYST1 143.220 143.220 46.410 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006982 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021547 0.00000